Metabolic

Obesity grew at more than 50% a year between 2019 and 2026 and is forecast to lead every therapy area again to 2033. Evaluate’s experts discuss the leading products and companies, payer coverage, an early-stage pipeline and dealmaking, and where differentiation comes next.
32 minutes

–

On demand

ML
Mark Lansdell
Director, Asset & Portfolio Strategy
JH
Jack Hughes​
Senior Analyst ​

Register free to unlock

Full episode video

Companion short report

Blog post & thought leadership

Scroll down to register — one form unlocks everything on this page.








Episode Video

Watch now

32 minutes

What the episode covers

Evaluate Consulting

Data into direction. Partnership into purpose.

Want to go deeper? Evaluate’s consulting team provides bespoke analysis on market sizing, pipeline strategy, BD&L, and competitive intelligence.